Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.338 USD | +0.87% | +28.82% | -74.37% |
May. 02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
Apr. 30 | Mustang Bio Prices Public Offering of 16.9 Million Shares, Accompanying Warrants | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.89M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -24M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.52
x | P/E ratio 2025 * |
-0.88
x | Employees | 80 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.88% |
1 day | +7.40% | ||
1 week | +28.93% | ||
Current month | +35.12% | ||
1 month | -1.90% | ||
3 months | -74.02% | ||
6 months | -80.05% | ||
Current year | -75.18% |
Managers | Title | Age | Since |
---|---|---|---|
Manuel Litchman
CEO | Chief Executive Officer | 70 | 17-04-23 |
James Murphy
DFI | Director of Finance/CFO | 67 | Jan. 18 |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 15-03-12 | |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 15-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 0.3474 | +3.69% | 10 777 |
24-05-20 | 0.3351 | +7.40% | 294,595 |
24-05-17 | 0.312 | +3.97% | 184,277 |
24-05-16 | 0.3001 | +8.54% | 490,983 |
24-05-15 | 0.2765 | +2.94% | 79,980 |
Delayed Quote Nasdaq, May 20, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-75.18% | 3.89M | |
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.49% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- MBIO Stock